ENDS US 2017 Advisory Board

Smithers Rapra is proud to work with the following renowned experts to shape and guide the ENDS US 2017 conference.

  • Gregory G. Brown

    General Counsel Space Jam Juice

    Gregory G. Brown is General Counsel and Corporate Secretary of Space Jam Juice, LLC, a leading e-liquid and e-cigarette device manufacturer and distributor.  Headquartered in the United States, Space Jam Juice, LLC manufactures and distributes premium e-liquids and devices through out the world.

    Brown has been a practicing business and corporate lawyer for 30 years and a partner in the Southern California law firm of Brown & Charbonneau, LLP.  Brown has focused much of his experience to a variety of emerging and manufacturing industries, including the e-cigarette industry.  Since early 2015, Brown has been deeply involved in worldwide e-cigarette regulations and issues, including the EU Tobacco Products Directive and the US Food & Drug Administrations deeming regulations.  Brown has spoken and written to industry and stakeholders throughout his career, most recently as a panelist at the June 2017 ENDS Conference in London.

    Brown is a highly regarded business lawyer and has received countless awards and recognition from his peers.  He has been named one of the Forbes Magazine’s “Legal Leaders” and has been recognized as one of the “Best Lawyers in America” by the US News and World Report. He has been awarded the highly coveted “AV Preeminent Rating” by Martindale – Hubbell, which is the highest possible rating, signifying that his peers rank him at the highest level of professional excellence.  Brown has also been named to Super Lawyers for the last eight years, which signifies the top 5% of lawyers.  With extensive trial experience, Brown was accepted into to the American Board of Trial Advocates and is a Board Certified Trial Specialist.

    Brown graduated from the University of San Diego School of Law in 1987 where he was named to the San Diego Law Review and was a founding editor the Journal of Contemporary Legal Issues.  Brown has also received extensive Mediation and Alternative Dispute Resolution training and experience, having graduated from the renowned Strauss Institute for Dispute Resolution in Malibu, California.

    Brown grew up in Southern California and is married with 5 children. 

  • Azim Chowdhury

    Partner Keller and Heckman LLP

    Azim Chowdhury practices food, tobacco and e-vapor law in the Washington, D.C. office of Keller and Heckman LLP. Mr. Chowdhury advises domestic and foreign corporations in matters of Food and Drug Administration (FDA) and international regulatory compliance. In particular, he assists corporations in establishing clearances for food and drug additives in the U.S., Canada, and European Union, with an emphasis on indirect additives used in food-contact materials. Mr. Chowdhury has also developed expertise in tobacco product regulation and spearheaded the Tobacco and E-Vapor practice at Keller and Heckman. Specifically, Mr. Chowdhury has experience representing tobacco and electronic vapor product (e-cigarette) manufacturers, suppliers, and trade associations in matters of FDA regulatory and corporate compliance. He is also a frequent contributor to the Tobacco Reporter and the Food and Drug Law Institute’s Update magazine; edited and co-authored FDLI’s tobacco regulation manuals, Tobacco Regulation and Compliance: An Essential Resource and Tobacco and Nicotine Delivery: Regulation and Compliance, 2nd Edition; and previously served on the Editorial Advisory Board of the Food and Drug Law Journal.  Prior to entering private practice, he served as a judicial law clerk on the Court of Special Appeals of Maryland.  Mr. Chowdhury received a B.A. and B.S. from Johns Hopkins University, a MBA from the University of Maryland Robert H. Smith School of Business, and a JD, cum laude, from the University of Maryland School of Law.

  • Dr. Ian M. Fearon

    Principal Scientist and Head of Clinical Research British American Tobacco

    Ian is a Principal Scientist and Head of Clinical Research at British American Tobacco's central research and development center in Southampton, U.K. He specializes in the biological and psychological effects of nicotine, clinical studies to assess the biological effects of electronic cigarettes and tobacco heating devices, and the scientific basis for regulation.  Prior to joining BAT in 2008, Ian pursued an academic career as a Lecturer in Physiology at the University of Manchester and an Assistant Professor at McMaster University in Hamilton, Canada.  Ian is a highly-cited scientific researcher and writer, contributing to more than 50 peer-reviewed papers and book chapters and generating over 1,900 citations.

  • David Graham

    Chief Impact Officer NJOY

    David has extensive experience in nicotine and non-nicotine new product development, tobacco control policy, and related regulation in the international healthcare and e-vapor industries spanning ~ 24 years. Beginning in the pharmaceutical industry with nicotine replacement therapy/smoking cessation products in 1992, he left Johnson & Johnson to join NJOY in 2013 to lead the regulatory affairs, quality & compliance function for the company and prepare for regulation by FDA and other regulatory agencies in the US and abroad. In addition to multiple interactions with FDA while at NJOY, David co-led NJOY’s engagement with the National Institute of Drug Abuse (NIDA) on its Small Business Innovation Research (SBIR) award for NJOY to develop an Electronic Nicotine Delivery System (ENDS) for use for clinical research in smoking cessation, leading to the establishment of the first FDA Drug Master File (DMF) for ENDS products. Recently, David co-founded and is now President of Reveritas Group, a multi-partner consultancy firm of specialists and preferred providers that is uniquely placed to aid ENDS companies navigate all aspects of FDA’s Premarket Tobacco Application (PMTA) process via a total programming approach, and/or provide select outsourced resources as required. David is a graduate of Columbia University with a Master’s in Public Policy & Administration.

  • Patricia I. Kovacevic

    General Counsel and Chief Compliance Officer Nicopure Labs LLC

    Patricia I. Kovacevic is the General Counsel and Chief Compliance Officer of Nicopure Labs LLC, a leading international e-liquid and vaping device manufacturer of U.S.- made Halo, Purity and eVo e-liquids. With extensive U.S. and international legal and regulatory experience, Kovacevic held senior legal and compliance positions at, among others, Philip Morris International and Lorillard. Prior to joining Lorillard she was a partner at Patton Boggs. Her expertise includes global nicotine, e-cigarette and tobacco regulation, compliance and all regulatory aspects of marketing/media communications, corporate affairs, criminal investigations, FCPA, trade sanctions, privacy and government affairs. Kovacevic serves on the board of directors of the Vapor Technology Association and on the advisory board of the Global Tobacco & Nicotine Forum. In the past she was a United Nations staff member, served on the U.N.’s Public-Private Partnership Commission and was also an adviser to various industry conferences. Kovacevic is admitted to practice in New York and before the Supreme Court of the United States. She holds a J.D. from Columbia Law School in New York and has completed the Harvard Business School “Corporate Leader” course. She is fluent in seven European languages.